×
About 8,543 results

ALLMedicine™ Antiphospholipid Syndrome Center

Research & Reviews  4,167 results

Increased heterogeneity of brain perfusion predicts the development of cerebrovascular ...
https://doi.org/10.1097/MD.0000000000025557
Medicine Lin TS, Hsu PY et. al.

Apr 13th, 2021 - The heterogeneity of brain perfusion is related to the risk factors of thromboembolic events such as antiphospholipid syndrome. However, the effectiveness of brain perfusion heterogeneity as a marker to predict thromboembolic events has not been c...

Catastrophic antiphospholipid syndrome and posterior ocular involvement: case series of...
https://doi.org/10.1097/IAE.0000000000003185
Retina (Philadelphia, Pa.); Morel N, Bonnet C et. al.

Apr 12th, 2021 - To describe the posterior ophthalmic manifestations of catastrophic antiphospholipid syndrome (CAPS). Retrospective case series of patients presenting with CAPS and posterior segment ocular manifestations. The main outcomes were the type of poster...

Risk factors for pregnancy morbidity in women with antiphospholipid syndrome.
https://doi.org/10.1016/j.jri.2021.103315
Journal of Reproductive Immunology; Yang J, Liang M

Apr 12th, 2021 - Antiphospholipid syndrome (APS) increases the risk of obstetric complications, but risk factors for pregnancy morbidity in women with APS remain incompletely characterized. This retrospective study included pregnant women with APS and a control gr...

Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040358
Journal of Thrombosis and Thrombolysis; Roncati L, Corsi L et. al.

Apr 12th, 2021 - Coronavirus disease 2019 (COVID-19) is a complex disease with many clinicopathological aspects, including abnormal immunothrombosis, and the full comprehension of its pathogenetic mechanisms is urgently required. By means of a multidisciplinary ap...

Cardiovascular Considerations in Anesthetic Management for a Patient With Antiphospholi...
https://doi.org/10.2344/anpr-67-03-07
Anesthesia Progress; Shibuya M, Kimura Y et. al.

Apr 7th, 2021 - This case report describes the prolonged general anesthetic management of a 41-year-old woman with antiphospholipid syndrome (APS), systemic lupus erythematosus, and previously undiagnosed decreased cardiac function who underwent planned partial r...

see more →

Guidelines  5 results

European evidence-based recommendations for diagnosis and treatment of paediatric antip...
https://doi.org/10.1136/annrheumdis-2016-211001
Annals of the Rheumatic Diseases; Groot N, de Graeff N et. al.

May 5th, 2017 - Antiphospholipid syndrome (APS) is rare in children, and evidence-based guidelines are sparse. Consequently, management is mostly based on observational studies and physician's experience, and treatment regimens differ widely. The Single Hub and A...

EULAR recommendations for women's health and the management of family planning, assiste...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446003
Annals of the Rheumatic Diseases; Andreoli L, Bertsias GK et. al.

Jul 27th, 2016 - Develop recommendations for women's health issues and family planning in systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS). Systematic review of evidence followed by modified Delphi method to compile questions, elicit exper...

Practice Bulletin No. 132: Antiphospholipid syndrome.
https://doi.org/10.1097/01.AOG.0000423816.39542.0f
Obstetrics and Gynecology;

Nov 21st, 2012 - Antiphospholipid syndrome (APS) is an autoimmune disorder defined by the presence of characteristic clinical features and specified levels of circulating antiphospholipid antibodies (Box 1 and Box 2). Diagnosis requires that at least one clinical ...

Guidelines on the investigation and management of antiphospholipid syndrome.
https://doi.org/10.1111/j.1365-2141.2012.09037.x
British Journal of Haematology; Keeling D, Mackie I et. al.

Feb 8th, 2012 - Guidelines on the investigation and management of antiphospholipid syndrome.|2012|Keeling D,Mackie I,Moore GW,Greer IA,Greaves M,|diagnosis,therapy,

ACOG Practice Bulletin No. 118: antiphospholipid syndrome.
https://doi.org/10.1097/AOG.0b013e31820a61f9
Obstetrics and Gynecology;

Dec 21st, 2010 - ACOG Practice Bulletin No. 118: antiphospholipid syndrome.|2010||

see more →

Clinicaltrials.gov  4,253 results

Managing Diffuse Peripheral Ischemia in Antiphospholipid Syndrome: Anticoagulation, Immunosuppression, or Vasodilation?
https://www.medscape.com/viewarticle/948988

Apr 13th, 2021 - This article originally appeared on Hospital for Special Surgery's website. Case Report A 39-year-old man with a history of well-controlled type 1 diabetes (T1D) since childhood and migraine presented with 1 week of pain and cyanosis of the finger...

Increased heterogeneity of brain perfusion predicts the development of cerebrovascular ...
https://doi.org/10.1097/MD.0000000000025557
Medicine Lin TS, Hsu PY et. al.

Apr 13th, 2021 - The heterogeneity of brain perfusion is related to the risk factors of thromboembolic events such as antiphospholipid syndrome. However, the effectiveness of brain perfusion heterogeneity as a marker to predict thromboembolic events has not been c...

Catastrophic antiphospholipid syndrome and posterior ocular involvement: case series of...
https://doi.org/10.1097/IAE.0000000000003185
Retina (Philadelphia, Pa.); Morel N, Bonnet C et. al.

Apr 12th, 2021 - To describe the posterior ophthalmic manifestations of catastrophic antiphospholipid syndrome (CAPS). Retrospective case series of patients presenting with CAPS and posterior segment ocular manifestations. The main outcomes were the type of poster...

Risk factors for pregnancy morbidity in women with antiphospholipid syndrome.
https://doi.org/10.1016/j.jri.2021.103315
Journal of Reproductive Immunology; Yang J, Liang M

Apr 12th, 2021 - Antiphospholipid syndrome (APS) increases the risk of obstetric complications, but risk factors for pregnancy morbidity in women with APS remain incompletely characterized. This retrospective study included pregnant women with APS and a control gr...

Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040358
Journal of Thrombosis and Thrombolysis; Roncati L, Corsi L et. al.

Apr 12th, 2021 - Coronavirus disease 2019 (COVID-19) is a complex disease with many clinicopathological aspects, including abnormal immunothrombosis, and the full comprehension of its pathogenetic mechanisms is urgently required. By means of a multidisciplinary ap...

see more →

News  113 results

Managing Diffuse Peripheral Ischemia in Antiphospholipid Syndrome: Anticoagulation, Immunosuppression, or Vasodilation?
https://www.medscape.com/viewarticle/948988

Apr 13th, 2021 - This article originally appeared on Hospital for Special Surgery's website. Case Report A 39-year-old man with a history of well-controlled type 1 diabetes (T1D) since childhood and migraine presented with 1 week of pain and cyanosis of the finger...

'Hypercoagulation,' Antiphospholipid Antibodies Seen in COVID-19
https://www.staging.medscape.com/viewarticle/928653

Apr 13th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. COVID-19 infection may represent a "hypercoagulable" state, new research suggests. Researchers from China describe three patients admitted to the...

'Hypercoagulation,' Antiphospholipid Antibodies Seen in COVID-19
https://www.medscape.com/viewarticle/928653

Apr 13th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. COVID-19 infection may represent a "hypercoagulable" state, new research suggests. Researchers from China describe three patients admitted to the...

Trending Clinical Topic: Warfarin
https://reference.medscape.com/viewarticle/920469

Oct 31st, 2019 - Each week, we identify one top search term, speculate as to what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, feel free to share them with us on Twitter or Facebook. ...

Rivaroxaban Misfires in Antiphospholipid Syndrome
https://www.medscape.com/viewarticle/920015

Oct 16th, 2019 - Thrombosis is one of the clinical hallmarks of antiphospholipid syndrome (APS), but anticoagulant treatment with rivaroxaban (Xarelto, Janssen Pharmaceuticals) may not be the optimal choice. Findings from a new randomized study failed to show that...

see more →

Patient Education  5 results see all →